Publikation

Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.

Wissenschaftlicher Artikel/Review - 11.02.2023

Bereiche
PubMed
DOI
Kontakt

Zitation
Jensen A, Renström F, Aczel S, Folie P, Biraima M, Beuschlein F, Bilz S. Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study. Obes Surg 2023:1-9.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Obes Surg 2023
Veröffentlichungsdatum
11.02.2023
eISSN (Online)
1708-0428
Seiten
1-9
Kurzbeschreibung/Zielsetzung

Weight regain after bariatric surgery occurs in up to a third of patients and reduces treatment-associated health benefits. The efficacy of glucagon-like peptide-1 receptor agonists (GLP1-RA) for treatment of type 2 diabetes mellitus and obesity is well established, but their role in the treatment of weight regain after bariatric surgery remains to be defined.